Is (LVGO) Outperforming Other Medical Stocks This Year?
Livongo Health (LVGO) delivered earnings and revenue surprises of 300.00% and 11.02%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
MOUNTAIN VIEW, Calif. (AP) _ Livongo Health Inc. (LVGO) on Wednesday reported a loss of $25.5 million in its third quarter.
-- Third quarter total revenue of $106.1 million, up 126% year-over-year
In Q3, Medical Product stocks are expected to have gained from gradual lifting of restrictions in many states and regions. However, international sales might have been dampened.
Livongo Health's (LVGO) third-quarter results are likely to reflect growth in core Livongo for Diabetes solution.
Teladoc Health (TDOC) rolls out a new telemedicine solution to address mental health issues of Canadian employees.
Livongo Health (LVGO) closed at $142.75 in the latest trading session, marking a -0.39% move from the prior day.
, /PRNewswire/ -- GuideWell Mutual Holding Corporation (), the parent to a family of forward-thinking companies focused on transforming health care, announced a strategic agreement today with Livongo...
, /PRNewswire/ -- The era of telehealth is upon us. As patients try to avoid hospital rooms right now, a growing number of people have turned to telehealth from the comfort of their home to limit contact...